Core competency domains | Detailed assessment criteria of clinical performance skill | Performance rate of students with successful demonstrations of skill, mean (SD) |
---|---|---|
Patient counseling | 1. Perform a brief greeting and self-introduction | 50.0 |
2. Identify the patient | 10.0 | |
3. Explain the purpose of patient counseling | 31.3 (11.4)* | |
4. Explain expected length of the patient counseling session | 0 | |
5. Explain the dosage and proper use of inhaled corticosteroids, according to the prescription | 47.5 (21.9)* | |
6. Explain, both verbally and clearly, how to use the inhaler | ||
6–1. Hold the body horizontally with your left hand, put your right hand in the handle groove, and turn until you hear a snap | 53.8 (24.8) | |
6–2. Turn the operating lever until it makes a “clap” sound | 50.0 (18.4) | |
6–3. Turn your head to the side and exhale all the way to prepare for inhalation | 33.8 (18.2)* | |
6–4. Hold the inlet in your mouth and inhale it all the way, strong and deep | 38.8 (20.7)* | |
6–5. Take the inhaler out of your mouth and hold your breath for approximately 5–10 s to ensure that the drug is absorbed as much as possible | 42.5 (21.9)* | |
6–6. Exhale naturally and slowly through your nose | 15.0 (12.7) | |
6–7. Hold the handle and turn the lid to the left until you hear a snap | 37.5 (13.0)* | |
6–8. Rinse your mouth and throat with water after inhalation | 50.0 (20.3)* | |
7. Demonstrate the correct use of the inhaler | 23.8 (12.4)* | |
8. Let the patient demonstrate the use of the inhaler | 23.8 (5.4) | |
9. Watch the patient’s demonstration and provide appropriate feedback | 30.0 (12.2) | |
10. Ask the patient if they have any questions or concerns | 57.5 (5.6) | |
11. Allow patients to summarize and organize the relevant education and counseling | 0 | |
Sub-total | 32.1 (22.9) | |
Prescription review | 1. Note that the physician’s signature on the prescription is missing | 20.0 |
2. Note that the prescription expiration date is missing | 40.0 | |
3. Check the patient’s age | 30.0 (14.6)* | |
4. Check the patient’s body weight | 77.5 (5.6) | |
5. Check the appropriate pediatric dosage by referring to the instructions for use | 85.0 (6.1) | |
6. Note the inappropriate dose in the prescription | 80.0 (11.2) | |
7. Note the inappropriate duration of treatment | 71.3 (11.4) | |
8. Suggest the appropriate dosage to the patient | 80.0 (5.0) | |
9. Suggest the appropriate daily dose to the patient | 78.8 (6.5) | |
10. Calculate the proper dose (mg) according to the patient’s body weight | 68.8 (8.9) | |
11. Convert the calculated dose (mg) to volumes (ml) | 73.8 (8.9) | |
12. Use the appropriate terms | 73.8 (14.3) | |
13. Answer with confidence | 50.0 (21.2)* | |
14. Answer with respect to the other person | 95.0 (5.0) | |
Sub-total | 64.8 (23.6) | |
Drug information service | 1. Reconfirm the question clearly | 36.3 (34.0)* |
2. Find an appropriate drug information resource for the drug’s identification | 90.0 (3.5) | |
3. Identify the drug using the drug database | 91.3 (4.1)* | |
4. Check the information about drug interaction with Naproxen by using the appropriate data sources or evidence | 73.8 (15.6)* | |
5. Provide proper information on the drug identification results | 77.5 (17.5)* | |
6. Provide proper information on naproxen coadministration | 23.8 (12.9)* | |
Sub-total | 65.4 (31.6) | |
OTC counseling | 1. Identify the patient’s symptoms and needs | 90.0 (9.4)* |
2. Ask for more information to provide the best treatment choice | 68.8 (23.3)* | |
3. Select at least one product and provide information | 95.0 (5.0) | |
4. Provide information about a diarrhea-related diet | 65.0 (9.4) | |
Sub-total | 79.7 (18.8) | |
Pharmaceutical care service | 1. Check the current dose of methylprenisonlone | 70.0 |
2. Check the corticosteroid dose equivalents for the dosing conversion from methylprednisolone to oral prednisolone | 56.3 (4.1) | |
3. The converted daily dose of oral prednisolone was designed using the appropriate number of tablets and frequency, considering the formulation and dose of those on the market | 37.5 (21.4)* | |
4. Inform the patient that after long-term steroid systemic therapy, treatment should be gradually stopped through a tapering process | 86.3 (4.1) | |
Sub-total | 62.5 (21.1) | |
Total | 50.8 (29.8) |